Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib + BCVP-R in Advanced Follicular Non-Hodgkin's Lymphoma
NCT00428142Phase 2Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- May 2007
- Primary completion
- Apr 2011
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in follicular lymphoma (FL), sponsored by Canadian Cancer Trials Group. Started May 2007; status: completed.
02
Drugs
bortezomib
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00428142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00428142.